Gary Rothbard, MD, MS

All articles by Gary Rothbard, MD, MS

Intravenous IV Vasodilators Remain the First-Line Therapy of Choice for Severe H-AHF

April 20, 2021

Researchers review the primary clinical and research questions regarding blood pressure (BP) reduction with vasodilators in the early management of hypertensive acute heart failure (H-AHF).

Woman smiling with her mouth open slightly.

Medicine, News

Examining the Associations Between Oral Nitrate-Reducing Bacteria and Cardiometabolic Outcomes

Gary Rothbard, MD, MS

January 13, 2020

A greater quantity of oral nitrate-reducing bacteria was found to be associated with reduced plasma glucose and insulin resistance in young to middle-aged adults.

Next post in Medicine

Gary Rothbard, MD, MS

All articles by Gary Rothbard, MD, MS

Intravenous IV Vasodilators Remain the First-Line Therapy of Choice for Severe H-AHF

Examining the Associations Between Oral Nitrate-Reducing Bacteria and Cardiometabolic Outcomes

Moderate Exercise Associated With Improved Glucose Regulation in Older Men